These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25896138)

  • 1. Intrathecal morphine therapy in the management of status dystonicus in neurodegeneration brain iron accumulation type 1.
    Lopez WO; Kluge Schroeder H; Santana Neville I; Jacobsen Teixeira M; Costa Barbosa D; Assumpçao de Mônaco B; Talamoni Fonoff E
    Pediatr Neurosurg; 2015; 50(2):94-8. PubMed ID: 25896138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy.
    Kyriagis M; Grattan-Smith P; Scheinberg A; Teo C; Nakaji N; Waugh M
    J Paediatr Child Health; 2004; 40(5-6):322-5. PubMed ID: 15151592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.
    Timmermann L; Pauls KA; Wieland K; Jech R; Kurlemann G; Sharma N; Gill SS; Haenggeli CA; Hayflick SJ; Hogarth P; Leenders KL; Limousin P; Malanga CJ; Moro E; Ostrem JL; Revilla FJ; Santens P; Schnitzler A; Tisch S; Valldeoriola F; Vesper J; Volkmann J; Woitalla D; Peker S
    Brain; 2010 Mar; 133(Pt 3):701-12. PubMed ID: 20207700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation for pantothenate kinase-associated neurodegeneration: A meta-analysis.
    De Vloo P; Lee DJ; Dallapiazza RF; Rohani M; Fasano A; Munhoz RP; Ibrahim GM; Hodaie M; Lozano AM; Kalia SK
    Mov Disord; 2019 Feb; 34(2):264-273. PubMed ID: 30633810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia.
    Lumsden DE; Kaminska M; Gimeno H; Tustin K; Baker L; Perides S; Ashkan K; Selway R; Lin JP
    Dev Med Child Neurol; 2013 Jun; 55(6):567-74. PubMed ID: 23452222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Status dystonicus and Hallervorden-Spatz disease.
    Flett PJ
    J Paediatr Child Health; 2004 Dec; 40(12):721. PubMed ID: 15569297
    [No Abstract]   [Full Text] [Related]  

  • 7. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. Case report.
    Umemura A; Jaggi JL; Dolinskas CA; Stern MB; Baltuch GH
    J Neurosurg; 2004 Apr; 100(4):706-9. PubMed ID: 15070127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease.
    Balas I; Kovacs N; Hollody K
    Mov Disord; 2006 Jan; 21(1):82-5. PubMed ID: 16108022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vivo canine study to assess granulomatous responses in the MedStream Programmable Infusion System (TM) and the SynchroMed II Infusion System®.
    Michael A; Buffen E; Rauck R; Anderson W; McGirt M; Mendenhall HV
    Pain Med; 2012 Feb; 13(2):175-84. PubMed ID: 22239738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.
    Cossu G; Abbruzzese G; Matta G; Murgia D; Melis M; Ricchi V; Galanello R; Barella S; Origa R; Balocco M; Pelosin E; Marchese R; Ruffinengo U; Forni GL
    Parkinsonism Relat Disord; 2014 Jun; 20(6):651-4. PubMed ID: 24661465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.
    Saeedi Y; Kazemi F; Habibi SAH; Tafakhori A; Chitsaz A; Fasano A; Lang AE; Rohani M
    Pediatr Neurol; 2020 Feb; 103():76-78. PubMed ID: 31371123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ¹⁸F-FDG PET imaging in paediatric primary dystonia and dystonia arising from neurodegeneration with brain iron accumulation.
    Szyszko TA; Dunn JT; O'Doherty MJ; Reed L; Lin JP
    Nucl Med Commun; 2015 May; 36(5):469-76. PubMed ID: 25646707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the Burke-Fahn-Marsden Dystonia Rating Scale: deep brain stimulation in childhood secondary dystonia.
    Gimeno H; Tustin K; Selway R; Lin JP
    Eur J Paediatr Neurol; 2012 Sep; 16(5):501-8. PubMed ID: 22258088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical improvement of secondary focal limb dystonia in neurodegenerative disease following a five-day lidocaine infusion: a case report.
    Irwin D; Revuelta G; Lippa CF
    J Neurol Sci; 2009 Feb; 277(1-2):164-6. PubMed ID: 19013587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurodegeneration with brain iron accumulation, type-I (NBIA-I) (formerly Hallervorden-Spatz, disease). Par I: clinical manifestation and treatment].
    Bertrand E
    Neurol Neurochir Pol; 2002; 36(5):947-58. PubMed ID: 12523119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 neurodegeneration with brain iron accumulation: a case report.
    Labrada-Aguilera PE; Guach-Hevia DA; Almira-Gómez CR; González-Lago DA
    J Med Case Rep; 2022 Jun; 16(1):217. PubMed ID: 35655240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status dystonicus in pantothenate kinase-associated neurodegeneration due to internal pulse generator depletion: Case study and literature review.
    Li H; Zhang C; Pan Y; Sun B; Li D; Wu Y
    J Neurol Sci; 2019 May; 400():44-46. PubMed ID: 30903858
    [No Abstract]   [Full Text] [Related]  

  • 19. The complications of scar formation associated with intrathecal pump placement.
    Protopapas MG; Bundock E; Westmoreland S; Nero C; Graham WA; Nesathurai S
    Arch Phys Med Rehabil; 2007 Mar; 88(3):389-90. PubMed ID: 17321835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic pain of oncologic origin with epidural or intrathecal morphine administered by continuous or programmable flow implanted pumps].
    Rodríguez López MJ; de la Torre Liébanas M; Sánchez-Guijo Bernal JJ; Muñoz de la Guardia JL
    Rev Esp Anestesiol Reanim; 1990; 37(6):339-45. PubMed ID: 2098877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.